Markets and supply
New editionUK pharmaceutical market report 2026
The UK pharmaceutical market mapped: how it is structured, how medicines are priced and reimbursed, and where growth and pressure are coming from.
From £349
Out now: the UK pharmaceutical market report, 2026 edition. See the report
Why medicines go short, how the UK supply chain is organised, and what manufacturers, wholesalers and pharmacies are doing about it.
This is a digital research report. It doesn't promote or supply any medicine, and nothing in it is medical, clinical, legal or investment advice.
Medicine shortages are a recurring risk for everyone in the supply chain. This briefing sets out the causes that are documented in published research and official reports, how the UK supply chain is organised, and the responses in use or under discussion.
It is general information for business use and does not advise on the supply of any individual medicine.
UK, with reference to EU developments. Government and regulator publications, parliamentary and audit reports, peer-reviewed research.
Markets and supply
New editionThe UK pharmaceutical market mapped: how it is structured, how medicines are priced and reimbursed, and where growth and pressure are coming from.
From £349
Markets and supply
How the UK generics and biosimilars markets work, who competes in them, and what drives pricing, switching and supply.
From £249